"After listening to the event CC, I concluded that the drug did not fail; rather, AZN's trials were designed for failure"
Interesting theory. Are you saying that AZN partnered the drug just to prevent the competition and then made it fail to keep its market share? Sounds like conspiracy theory but eh. I doubt enough drugs make it through phase 3 in cancer to justify such a strategy.
Thomas any thoughts on todays financing? I don't follow array too close these days. The large amount of warrants bothers me as I am a longer term shareholder plus paying a fee in addition to interest. I think if I am a shareholder I would have preferred the straight issuance of equity at a discount to share price.
Do you buy chance have a list of near term catalysts? TIA
News 
Market Data 
Discover 
